VSUL nice 8k out Issuance of Eleventh Patent on its ChromaID™ technology
On May 9, 2017, Visualant, Incorporated (the “Company”), an emerging leader in next-generation optical sensor technology, announced that it had received its eleventh patent relating to its ChromaID™ technology.
The Company’s recently announced Joint Development Agreement with Biomedx, which is focused on the properties of human skin, falls squarely within the scope of the newly issued patent. That agreement provides for the use of ChromaID to analyze collagen and elastin as an aid in plastic reconstructive and cosmetic surgery.
The patent, issued by the United States Patent and Trademark Office as US Patent No. 9,625,371 B2, is entitled “Method, Apparatus, and Article to Facilitate Evaluation of Substances Using Electromagnetic Energy.”
